# Ellington Financial Inc.: financial statements, quarterly

EFC · NYSE · CIK 1411342 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/efc.md) · [Financials](/companies/efc/financials.md) · [Filings](/companies/efc/filings.md) · [Insiders](/companies/efc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/efc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [68.7](/filings/0001411342-24-000113.md) | [70.7 d](/filings/0001628280-26-013279.md) | [70.5](/filings/0001411342-25-000052.md) | [66.9](/filings/0001411342-25-000077.md) | [73.7](/filings/0001628280-25-051038.md) | [68.6 d](/filings/0001628280-26-013279.md) | [72.7](/filings/0001628280-26-033463.md) | [72.1](/filings/0001628280-26-055148.md) | [73.1](/filings/0001628280-25-051038.md) | [86.6 d](/filings/0001628280-26-013279.md) | [88.2](/filings/0001628280-26-033463.md) | [98.6](/filings/0001628280-26-055148.md) |
| Income tax | $m | [0.2](/filings/0001411342-24-000113.md) | [0.1 d](/filings/0001628280-26-013279.md) | [0.1](/filings/0001411342-25-000052.md) | [0.1](/filings/0001411342-25-000077.md) | [0.0](/filings/0001628280-25-051038.md) | [0.4 d](/filings/0001628280-26-013279.md) | [(0.1)](/filings/0001628280-26-033463.md) | [1.5](/filings/0001628280-26-055148.md) | [1.1](/filings/0001628280-25-051038.md) | [1.4 d](/filings/0001628280-26-013279.md) | [1.0](/filings/0001628280-26-033463.md) | [0.1](/filings/0001628280-26-055148.md) |
| Net income | $m | [6.6](/filings/0001411342-24-000113.md) | [12.5 d](/filings/0001628280-26-013279.md) | [26.9](/filings/0001411342-25-000052.md) | [52.3](/filings/0001411342-25-000077.md) | [16.2](/filings/0001628280-25-051038.md) | [22.4 d](/filings/0001628280-26-013279.md) | [31.6](/filings/0001628280-26-033463.md) | [42.9](/filings/0001628280-26-055148.md) | [29.5](/filings/0001628280-25-051038.md) | [14.7 d](/filings/0001628280-26-013279.md) | [95.5](/filings/0001628280-26-033463.md) | [54.4](/filings/0001628280-26-055148.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001411342-24-000113.md) | not reported | [0.32](/filings/0001411342-25-000052.md) | [0.62](/filings/0001411342-25-000077.md) | [0.19](/filings/0001628280-25-051038.md) | not reported | [0.35](/filings/0001628280-26-033463.md) | [0.45](/filings/0001628280-26-055148.md) | [0.29](/filings/0001628280-25-051038.md) | not reported | [0.78](/filings/0001628280-26-033463.md) | [0.43](/filings/0001628280-26-055148.md) |
| Basic EPS | $ per share | [0.10](/filings/0001411342-24-000113.md) | not reported | [0.32](/filings/0001411342-25-000052.md) | [0.62](/filings/0001411342-25-000077.md) | [0.19](/filings/0001628280-25-051038.md) | not reported | [0.35](/filings/0001628280-26-033463.md) | [0.45](/filings/0001628280-26-055148.md) | [0.29](/filings/0001628280-25-051038.md) | not reported | [0.78](/filings/0001628280-26-033463.md) | [0.43](/filings/0001628280-26-055148.md) |

- Cost of revenue: not reported
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001411342-24-000113.md) | [0.2](/filings/0001628280-26-013279.md) | [0.2](/filings/0001411342-25-000052.md) | [0.2](/filings/0001411342-25-000077.md) | [0.2](/filings/0001628280-25-051038.md) | [0.2](/filings/0001628280-26-055148.md) | [0.2](/filings/0001628280-26-033463.md) | [0.2](/filings/0001628280-26-055148.md) | [0.2](/filings/0001628280-25-051038.md) | [0.2](/filings/0001628280-26-055148.md) | [0.2](/filings/0001628280-26-033463.md) | [0.2](/filings/0001628280-26-055148.md) |
| Total assets | $bn | [14.4](/filings/0001411342-23-000184.md) | [15.3](/filings/0001411342-25-000015.md) | [15.1](/filings/0001411342-24-000053.md) | [15.1](/filings/0001411342-24-000078.md) | [16.0](/filings/0001411342-24-000113.md) | [16.3](/filings/0001628280-26-013279.md) | [16.6](/filings/0001411342-25-000052.md) | [17.1](/filings/0001411342-25-000077.md) | [17.8](/filings/0001628280-25-051038.md) | [19.4](/filings/0001628280-26-055148.md) | [20.2](/filings/0001628280-26-033463.md) | [21.0](/filings/0001628280-26-055148.md) |
| Total liabilities | $bn | [13.1](/filings/0001411342-23-000184.md) | [13.8](/filings/0001411342-25-000015.md) | [13.6](/filings/0001411342-24-000053.md) | [13.5](/filings/0001411342-24-000078.md) | [14.3](/filings/0001411342-24-000113.md) | [14.7](/filings/0001628280-26-013279.md) | [15.0](/filings/0001411342-25-000052.md) | [15.4](/filings/0001411342-25-000077.md) | [16.0](/filings/0001628280-25-051038.md) | [17.5](/filings/0001628280-26-055148.md) | [18.3](/filings/0001628280-26-033463.md) | [19.0](/filings/0001628280-26-055148.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.3](/filings/0001411342-23-000184.md) | [1.5](/filings/0001411342-25-000015.md) | [1.5](/filings/0001411342-24-000053.md) | [1.6](/filings/0001411342-24-000078.md) | [1.6](/filings/0001411342-24-000113.md) | [1.6](/filings/0001628280-26-013279.md) | [1.6](/filings/0001411342-25-000052.md) | [1.7](/filings/0001411342-25-000077.md) | [1.8](/filings/0001628280-25-051038.md) | [1.8](/filings/0001628280-26-055148.md) | [1.9](/filings/0001628280-26-033463.md) | [2.0](/filings/0001628280-26-055148.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(70.9) d](/filings/0001411342-24-000113.md) | [(79.0) d](/filings/0001628280-26-013279.md) | [(59.5)](/filings/0001411342-25-000052.md) | [(88.6) d](/filings/0001411342-25-000077.md) | [(142) d](/filings/0001628280-25-051038.md) | [(141) d](/filings/0001628280-26-013279.md) | [(126)](/filings/0001628280-26-033463.md) | [(211) d](/filings/0001628280-26-055148.md) | [(290) d](/filings/0001628280-25-051038.md) | [(298) d](/filings/0001628280-26-013279.md) | [(10.0)](/filings/0001628280-26-033463.md) | [(19.1) d](/filings/0001628280-26-055148.md) |
| Dividends paid | $m | [36.8 d](/filings/0001411342-24-000113.md) | [42.0 d](/filings/0001628280-26-013279.md) | [40.0](/filings/0001411342-25-000052.md) | [40.3 d](/filings/0001411342-25-000077.md) | [40.9 d](/filings/0001628280-25-051038.md) | [42.4 d](/filings/0001628280-26-013279.md) | [42.9](/filings/0001628280-26-033463.md) | [44.7 d](/filings/0001628280-26-055148.md) | [46.6 d](/filings/0001628280-25-051038.md) | [49.5 d](/filings/0001628280-26-013279.md) | [55.3](/filings/0001628280-26-033463.md) | [53.7 d](/filings/0001628280-26-055148.md) |
| Share repurchases | $m | [0.0 d](/filings/0001411342-24-000113.md) | [0.0 d](/filings/0001628280-26-013279.md) | [0.5](/filings/0001411342-25-000052.md) | [0.2 d](/filings/0001411342-25-000077.md) | [0.0 d](/filings/0001628280-25-051038.md) | [0.0 d](/filings/0001628280-26-013279.md) | [0.0](/filings/0001411342-25-000052.md) | [0.0 d](/filings/0001411342-25-000077.md) | [0.0 d](/filings/0001628280-25-051038.md) | [0.0 d](/filings/0001628280-26-013279.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 128,887,386 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055148.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.